Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-005471
Filing Date
2023-01-30
Accepted
2023-01-30 16:13:27
Documents
1
Period of Report
2023-01-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5425
  Complete submission text file 0001209191-23-005471.txt   6737
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Issuer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9640 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address
Koenig Scott (Reporting) CIK: 0001587514 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36177 | Film No.: 23567875